Provide a breakdown of the used by the researchers in this study. Which of these would be most helpful for you?
: Both groups had roughly the same time (about 85–87 months) from their initial diagnosis until they started ibrutinib treatment. Clinical Implications (616 KB)
The study highlighted a few differences between "real-world" patients and those in trials: Provide a breakdown of the used by the
: Despite the high rate of stopping, the overall survival and progression-free survival (estimated at 35 months) remained excellent. Real-World vs. Clinical Trials the medical community should focus on:
The authors argue that because the drug is highly effective but often hard to tolerate, the medical community should focus on: